People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TrovaGene this week announced that it has named Antonius Schuh as CEO. Schuh previously served as chairman and CEO of Sorrento Therapeutics. He also has served as founding CEO of AviaraDx (now operating as BioTheranostics under parent company BioMérieux). Prior to that, he served as CEO of Arcturus, and president and CEO of Sequenom.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.